Investing.com - Merck&Co (NYSE:MRK) reported fourth quarter earnings that beat analysts' expectations on Friday and revenue that topped forecasts.
The firm reported earnings per share of $1.04 on revenue of $11B. Analysts polled by Investing.com expected EPS of $1.03 on revenue of $10.94B. That compared to EPS of $0.98 on revenue of $10.43B in the same period a year earlier. The company had reported EPS of $1.19 on revenue of $10.79B in the previous quarter.
For the year, Merck&Co shares are down 2.59%, under-performing the S&P Global (NYSE:SPGI) 100 which is up 5.89% year to date.
Merck&Co follows other major Healthcare sector earnings this month
On Tuesday, January 22, 2019, J&J reported fourth quarter EPS of $1.97 on revenue of $20.39B, compared to forecasts of EPS of $1.95 on revenue of $20.2B.
Pfizer earnings matched analyst's expectations on Tuesday, with fourth quarter EPS of $0.64 on revenue of $13.98B. Investing.com analysts expected EPS of $0.64 on revenue of $13.96B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar